Ahmed M. Hamdy - Dec 14, 2022 Form 4 Insider Report for Vincerx Pharma, Inc. (VINC)

Role
Chief Executive Officer, Director
Signature
/s/ Dr. Ahmed M. Hamdy
Stock symbol
VINC
Transactions as of
Dec 14, 2022
Transactions value $
$30,538
Form type
4
Date filed
12/14/2022, 08:22 PM
Previous filing
Nov 17, 2022
Next filing
Feb 16, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VINC Common Stock Purchase $30.5K +35.3K +91.68% $0.87 73.8K Dec 14, 2022 The Hamdy Family Trust dated 10/7/2015 F1
holding VINC Common Stock 1.62M Dec 14, 2022 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents a weighted average purchase price. Actual purchase prices ranged from $0.829 to $0.87 per share. Reporting person undertakes to provide upon request by the Securities and Exchange Commission, the issuer or a securityholder of the issuer detailed information regarding the price and number of shares purchased within the range indicated.